GT Medical Technologies

GT Medical Technologies is committed to improving the health of brain tumor patients. Its GammaTile™ therapy is a surgical targeted radiation therapy (STaRT™). After tumor resection, it provides timely and precise targeting of residual tumor cells that have not yet regained replicative capacity. The therapy aims to accurately target carcinogenic sites, completely eradicate any remaining tumor threats, and protect healthy brain tissue in patients. It is suitable for patients with recurrent intracranial tumors (brain tumors) and is characterized by high specificity and minimal side effects.